Can Both Anusol Suppository and Perineal External Cream Be Used Simultaneously?
Yes, using both the Anusol suppository (zinc oxide/lidocaine) and the Anusol perineal external cream (zinc oxide/lidocaine) at the same time is generally safe and may provide complementary symptom relief for anorectal conditions.
Rationale for Concurrent Use
The combination of rectal suppositories with external perianal creams follows established treatment principles for anorectal conditions. Guidelines for inflammatory bowel disease specifically support combining topical agents for enhanced symptom control 1. While these guidelines address ulcerative colitis and proctitis, the principle of combining internal (suppository) and external (cream) formulations applies to hemorrhoidal disease and other anorectal conditions.
Key Supporting Evidence:
- Topical agents may be added to provide additional benefit for troublesome rectal symptoms 1
- The combination addresses different anatomical areas: suppositories treat internal hemorrhoids and rectal mucosa, while external cream targets perianal skin and external hemorrhoids
- Research demonstrates that repeated anorectal administration of 5% lidocaine ointment (2.5g three times daily for 4 days) produces plasma concentrations well below toxic levels, with peak concentrations remaining an order of magnitude below toxic thresholds 2
Safety Considerations for Lidocaine
Systemic Absorption Profile:
When using both formulations simultaneously, you're applying lidocaine to different tissue types with distinct absorption characteristics:
- Anorectal lidocaine ointment (5% concentration, higher than Anusol) showed maximum plasma concentrations of only 145.9 ng/mL with repeated dosing—far below the 1,500 ng/mL therapeutic threshold and 5,000 ng/mL toxic level 2
- The FDA label for lidocaine topical preparations emphasizes using the lowest effective dose and warns about accumulation with repeated dosing 3
- Topical anesthetics applied to mucous membranes have higher systemic absorption than skin application, but even with this increased absorption, safety margins remain substantial 4
Practical Dosing Limits:
- Apply the suppository rectally as directed (typically 1-2 times daily)
- Apply external cream to perianal area as needed (typically 3-4 times daily)
- Avoid excessive or prolonged application beyond manufacturer recommendations
- The combined lidocaine exposure from both products should remain well within safe limits for most patients
Important Caveats and Monitoring
Watch for Signs of Systemic Toxicity:
While rare with topical anorectal use, be alert for 3:
- Lethargy or drowsiness
- Shallow breathing
- Seizure activity
- Metallic taste or perioral numbness
Special Populations Requiring Dose Adjustment:
The FDA label specifically warns that debilitated patients, elderly patients, acutely ill patients, and children should receive reduced doses 3. For these populations:
- Consider using only one formulation initially
- If using both, reduce frequency of application
- Monitor more closely for adverse effects
Contraindications:
- Known hypersensitivity to amide-type local anesthetics 3
- Avoid in patients with severe shock or heart block 3
Clinical Application Algorithm
Step 1: Determine primary symptom location
- Internal discomfort/bleeding → Start with suppository
- External irritation/pain → Start with external cream
- Both areas affected → Use both formulations
Step 2: Apply products at different times when possible
- Example: Suppository at bedtime, external cream 2-3 times during day
- This staggers lidocaine absorption and reduces peak plasma levels
Step 3: Monitor response over 3-7 days
- If symptoms improve with one formulation, consider discontinuing the other
- Continue both only if each provides distinct benefit
Step 4: Reassess if no improvement after 7 days
- May indicate need for alternative diagnosis or treatment
- Consider underlying conditions requiring different management
Bottom Line
The concurrent use of Anusol suppository and external cream is pharmacologically sound and clinically appropriate for managing combined internal and external anorectal symptoms. The safety profile of topical anorectal lidocaine, even at higher concentrations and frequencies than typical Anusol use, supports this approach 2. However, adhere to recommended dosing, avoid excessive application, and adjust for vulnerable populations 3.